REGISTERED
on 05 Dec 2023
Last Applicant/ Owned by
10573 W. Pico Blvd #58
Los Angeles
CA
90064
Serial Number
97645177 filed on 24th Oct 2022
Registration Number
7234591 registered on 05th Dec 2023
Filing Basis
1. filed as use application
2. use application currently
Disclaimer
NO DATA
IMMIX BIOPHARMA
scientific research in the field of oncology; scientific research in the field of immuo-dysregulated diseases; development of pharmaceutical preparations and medicines for the treatment of cancer; development of pharmaceutical preparations and medicines for the treatment of immuno-dysregulated diseases; clinical research in the field of oncology; clinical research in the field of immuo-dysregulate Read More
Classification Information
Class [044]
Medical, Beauty & Agricultural Services
providing medical information about the treatment of cancer; providing medical information about the treatment of immuno-dysregulated diseases; providing a website featuring healthcare and medical information, namely, information about cancer and the treatment of cancer; providing a website featuring healthcare and medical information, namely, information about immuno-dysregulated diseases and the treatment of immuno-dysregulated diseases
First Use Date in General
31st Dec 2012
First Use Date in Commerce
15th Oct 2013
Class [042]
Computer & Software Services & Scientific Services
scientific research in the field of oncology; scientific research in the field of immuo-dysregulated diseases; development of pharmaceutical preparations and medicines for the treatment of cancer; development of pharmaceutical preparations and medicines for the treatment of immuno-dysregulated diseases; clinical research in the field of oncology; clinical research in the field of immuo-dysregulated diseases; research and development services in the field of anti-cancer preparations; research and development services in the field of preparations for treating immuno-dysregulated diseases; pharmaceutical drug design, product engineering, pharmaceutical research, pharmaceutical drug development and pharmaceutical product quality testing services for others in the field of oncology; pharmaceutical drug design, product engineering, pharmaceutical research, pharmaceutical drug development and pharmaceutical product quality testing services for others in the field of immuno-dysregulated diseases; providing information regarding medical research relating to oncology; providing information regarding medical research relating to immuno-dysregulated diseases
First Use Date in General
31st Dec 2012
First Use Date in Commerce
15th Oct 2013
Mark Details
Serial Number
No 97645177
Mark Type
No Service Mark
Attorney Docket Number
No IMX-010UST
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 05th Dec 2023 | REGISTERED-PRINCIPAL REGISTER |
| 05th Dec 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 19th Sep 2023 | PUBLISHED FOR OPPOSITION |
| 19th Sep 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 30th Aug 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 10th Aug 2023 | EXAMINERS AMENDMENT -WRITTEN |
| 10th Aug 2023 | EXAMINERS AMENDMENT E-MAILED |
| 10th Aug 2023 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| 10th Aug 2023 | EXAMINER'S AMENDMENT ENTERED |
| 10th Aug 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |